Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Advertisement under Regulation 18(12) of the Securities and Exchange Board of ....
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Citigroup Global Markets India, the Manager to the Offer, has submitted the Post-Offer Advertisement to BSE under Regulation 18(12) of SEBI (SAST) Regulations. The open offer was for acquisition of up to 59,87,962 equity shares (26% of voting share capital) of Sanofi Consumer Healthcare India from public shareholders by Opal Bidco SAS together with Clayton, Dubilier & Rice Fund XII, L.P. as persons acting in concert. The Post-Offer Advertisement dated May 21, 2025 was published in Financial Express (English), Jansatta (Hindi), and Navshakti (Marathi) on May 23, 2025. The offer went through multiple stages starting from the public announcement on October 21, 2024, through the Letter of Offer on April 12, 2025, and the addendum on April 30, 2025.
This filing signals that the open offer process for Sanofi Consumer Healthcare India is in its final stage. The Post-Offer Advertisement is typically published after the tendering period closes, meaning the acquisition by Opal Bidco SAS and CD&R is now substantially complete, which may lead to changes in the company's controlling shareholder structure and board composition.